dysesthesia tirzepatide In four recent placebo-controlled clinical trials, dysesthesia, an unpleasant sensation that's perceived on or under the skin, was reported as a side effect of the GLP-1 agonist semaglutide in 5-23% of recipients Tirzepatide | DirectMeds

If you have been on a lower dose for a long time, either because you were having issues with side effects or because your doctor is being cautious, your body might not be getting the full effect of the medication

That gap matters because GLP-1 medications work best when combined with intentional dietary changes

Patients planning pregnancy GLP-1 medications must be discontinued before conception

It is important to remember that you should not discontinue tirzepatide without medical advice, as this medication provides significant benefits for glycaemic control and weight management

: Compounders that purchase these APIs would need to do so from green-listed sources that have undergone supplier qualification